Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Therapy of varicella-zoster virus infection — Mechanism of action of (E)-5-(2-bromovinyl)-2′-deoxyuridine — Shirô Shigeta (1985) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Therapy of varicella-zoster virus infection — Mechanism of action of (E)-5-(2-bromovinyl)-2′-deoxyuridine
Shared by
De Clercq Erik
KU Leuven
Therapy of varicella-zoster virus infection — Mechanism of action of (E)-5-(2-bromovinyl)-2′-deoxyuridine
Article
1985
en
Authors
SS
Shirô Shigeta
TY
Tomoyuki Yokota
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1982
In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds
De Clercq Erik
,
J Descamps
,
Masao Ogata
,
Shirô Shigeta
Article
1984
Comparative inhibition of DNA polymerases from varicella zoster virus (TK+ and TK-) strains by (E)-5-(2-bromovinyl)-2'-deoxyuridine 5'-triphosphate.
Tomoyuki Yokota
,
K Konno
,
Shirô Shigeta
,
De Clercq Erik
Chapter in a book
1981
On the Mechanism of Anti-Herpes Action of E-5-(2-Bromovinyl)-2′-Deoxyuridine
De Clercq Erik
,
J Descamps
Article
1980
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster.
De Clercq Erik
,
H. Degreef
,
J. Wildiers
,
Gabriela de Jonge
,
A Drochmans
,
J Descamps
,
P. De Somer
Article
1980
Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster infections
De Clercq Erik
,
H. Degreef
,
J. Wildiers
,
Gabriela de Jonge
,
A Drochmans
,
J Descamps
,
P. De Somer
Discussion(0)
No comments yet. Be the first to comment.